These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 8903476

  • 21. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
    Vickers PJ, Dickson RB, Shoemaker R, Cowan KH.
    Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
    [Abstract] [Full Text] [Related]

  • 22. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP, Leeding KS, Hu XF, DeLuise M, Zalcberg JR, Bach LA.
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
    Li Z, Wang N, Fang J, Huang J, Tian F, Li C, Xie F.
    Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
    Dumont JA, Bitonti AJ, Wallace CD, Baumann RJ, Cashman EA, Cross-Doersen DE.
    Cell Growth Differ; 1996 Mar; 7(3):351-9. PubMed ID: 8838865
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM, Howard EW, Dmytryk JJ, Pento JT.
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [Abstract] [Full Text] [Related]

  • 30. The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling.
    Martin LA, Pancholi S, Chan CM, Farmer I, Kimberley C, Dowsett M, Johnston SR.
    Endocr Relat Cancer; 2005 Dec; 12(4):1017-36. PubMed ID: 16322340
    [Abstract] [Full Text] [Related]

  • 31. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
    Tantivejkul K, Vucenik I, Eiseman J, Shamsuddin AM.
    Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 34. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line.
    Ercoli A, Scambia G, Fattorossi A, Raspaglio G, Battaglia A, Cicchillitti L, Malorni W, Rainaldi G, Benedetti Panici P, Mancuso S.
    Int J Cancer; 1998 Mar 30; 76(1):47-54. PubMed ID: 9533761
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.
    Robertson JF, Nicholson RI, Bundred NJ, Anderson E, Rayter Z, Dowsett M, Fox JN, Gee JM, Webster A, Wakeling AE, Morris C, Dixon M.
    Cancer Res; 2001 Sep 15; 61(18):6739-46. PubMed ID: 11559545
    [Abstract] [Full Text] [Related]

  • 36. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells.
    Diel P, Smolnikar K, Michna H.
    Breast Cancer Res Treat; 1999 Nov 15; 58(2):87-97. PubMed ID: 10674872
    [Abstract] [Full Text] [Related]

  • 37. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R, Li W, Zhang X, Zhang Y, Peng H, Xie Y, Fan D, Liu R, Liu X, Xiong D.
    Eur J Pharmacol; 2011 Nov 01; 669(1-3):38-44. PubMed ID: 21871878
    [Abstract] [Full Text] [Related]

  • 38. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB, Lykkesfeldt AE, Hansen JB, Stenvang J.
    Breast Cancer Res Treat; 2007 Aug 01; 104(2):165-79. PubMed ID: 17061041
    [Abstract] [Full Text] [Related]

  • 39. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
    Cook KL, Wärri A, Soto-Pantoja DR, Clarke PA, Cruz MI, Zwart A, Clarke R.
    Clin Cancer Res; 2014 Jun 15; 20(12):3222-32. PubMed ID: 24928945
    [Abstract] [Full Text] [Related]

  • 40. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.
    Whelan RD, Hill BT.
    Breast Cancer Res Treat; 1993 Jun 15; 26(1):23-39. PubMed ID: 8400321
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.